Amber B. Clemmons

Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial

Amber B. Clemmons, Julianne Orr, Benjamin Andrick et al. · Biology of Blood and Marrow Transplantation · 2018 · 54 citations · Full text

Emetogenic Chemotherapy, Oncology, Minimal Nausea +13

Development and implementation of a writing program to improve resident authorship rates

Amber B. Clemmons, Stephanie C. Hoge, Ashley Cribb et al. · American Journal of Health-System Pharmacy · 2015 · 26 citations

Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime

Amber B. Clemmons, Christine Flagstad Bech, Jeremy Pantin et al. · Biology of Blood and Marrow Transplantation · 2017 · 25 citations · Full text

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Megan E. Hartranft, Amber B. Clemmons, David L. DeRemer et al. · Journal of Oncology Pharmacy Practice · 2015 · 24 citations

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Morgan Gwynn, David L. DeRemer, Katherine Saunders et al. · Journal of Oncology Pharmacy Practice · 2019 · 22 citations